These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19147458)

  • 61. Association between left atrial myocardial function and exercise capacity in patients with either idiopathic or ischemic dilated cardiomyopathy: a two-dimensional speckle strain study.
    D'Andrea A; Caso P; Romano S; Scarafile R; Cuomo S; Salerno G; Riegler L; Limongelli G; Di Salvo G; Romano M; Liccardo B; Iengo R; Ascione L; Del Viscovo L; Calabrò P; Calabrò R
    Int J Cardiol; 2009 Mar; 132(3):354-63. PubMed ID: 18255178
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of myocardial deformation and velocity dyssynchrony for identification of responders to cardiac resynchronization therapy.
    Mele D; Toselli T; Capasso F; Stabile G; Piacenti M; Piepoli M; Giatti S; Klersy C; Sallusti L; Ferrari R
    Eur J Heart Fail; 2009 Apr; 11(4):391-9. PubMed ID: 19261620
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Real-time three-dimensional echocardiography permits quantification of left ventricular mechanical dyssynchrony and predicts acute response to cardiac resynchronization therapy.
    Marsan NA; Bleeker GB; Ypenburg C; Ghio S; van de Veire NR; Holman ER; van der Wall EE; Tavazzi L; Schalij MJ; Bax JJ
    J Cardiovasc Electrophysiol; 2008 Apr; 19(4):392-9. PubMed ID: 18179529
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of myocardial scarring on outcomes of cardiac resynchronization therapy: extent or location?
    Xu YZ; Cha YM; Feng D; Powell BD; Wiste HJ; Hua W; Chareonthaitawee P
    J Nucl Med; 2012 Jan; 53(1):47-54. PubMed ID: 22159181
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Quantitative gated SPECT-derived phase analysis on gated myocardial perfusion SPECT detects left ventricular dyssynchrony and predicts response to cardiac resynchronization therapy.
    Boogers MM; Van Kriekinge SD; Henneman MM; Ypenburg C; Van Bommel RJ; Boersma E; Dibbets-Schneider P; Stokkel MP; Schalij MJ; Berman DS; Germano G; Bax JJ
    J Nucl Med; 2009 May; 50(5):718-25. PubMed ID: 19403876
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Triplane tissue Doppler imaging: a novel three-dimensional imaging modality that predicts reverse left ventricular remodelling after cardiac resynchronisation therapy.
    Van de Veire NR; Yu CM; Ajmone-Marsan N; Bleeker GB; Ypenburg C; De Sutter J; Zhang Q; Fung JW; Chan JY; Holman ER; van der Wall EE; Schalij MJ; Bax JJ
    Heart; 2008 Mar; 94(3):e9. PubMed ID: 17984218
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Relationship between ultrasonic tissue characterization and myocardial deformation for prediction of left ventricular reverse remodelling in non-ischaemic dilated cardiomyopathy.
    Park SM; Kim YH; Ahn CM; Hong SJ; Lim DS; Shim WJ
    Eur J Echocardiogr; 2011 Dec; 12(12):887-94. PubMed ID: 21933792
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Left ventricular discoordination index measured by speckle tracking strain rate imaging predicts reverse remodelling and survival after cardiac resynchronization therapy.
    Wang CL; Powell BD; Redfield MM; Miyazaki C; Fine NM; Olson LJ; Cha YM; Espinosa RE; Hayes DL; Hodge DO; Lin G; Friedman PA; Oh JK
    Eur J Heart Fail; 2012 May; 14(5):517-25. PubMed ID: 22411692
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Assessment of right ventricular oxidative metabolism by PET in patients with idiopathic dilated cardiomyopathy undergoing cardiac resynchronization therapy.
    Knuuti J; Sundell J; Naum A; Engblom E; Koistinen J; Ylitalo A; Stolen KQ; Kalliokoski R; Nekolla SG; Bax KE; Airaksinen KE
    Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1592-8. PubMed ID: 15290120
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Classic-pattern dyssynchrony and electrical activation delays in pediatric dilated cardiomyopathy.
    Forsha D; Slorach C; Chen CK; Stephenson EA; Risum N; Hornik C; Wagner G; Mertens L; Barker P; Kisslo J; Friedberg MK
    J Am Soc Echocardiogr; 2014 Sep; 27(9):956-64. PubMed ID: 25063467
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Measures of left ventricular dyssynchrony and the correlation to clinical and echocardiographic response after cardiac resynchronization therapy.
    Abdelhadi R; Adelstein E; Voigt A; Gorcsan J; Saba S
    Am J Cardiol; 2008 Sep; 102(5):598-601. PubMed ID: 18721519
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Patients with non-ischaemic dilated cardiomyopathy and hyper-responders to cardiac resynchronization therapy: characteristics and long-term evolution.
    Castellant P; Fatemi M; Orhan E; Etienne Y; Blanc JJ
    Europace; 2009 Mar; 11(3):350-5. PubMed ID: 19240110
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of mitral regurgitation and myocardial viability on left ventricular reverse remodeling after cardiac resynchronization therapy in patients with ischemic cardiomyopathy.
    Sénéchal M; Lancellotti P; Magne J; Garceau P; Champagne J; Philippon F; O'Hara G; Moonen M; Dubois M
    Am J Cardiol; 2010 Jul; 106(1):31-7. PubMed ID: 20609643
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Which echocardiographic definition should be used to define response to cardiac resynchronization therapy?
    António N; Teixeira R; Lourenço C; Saraiva F; Coelho L; Martins R; Ventura M; Cristóvão J; Guimarães H; Elvas L; Gonçalves L; Providência LA
    Rev Port Cardiol; 2009 Sep; 28(9):943-58. PubMed ID: 19998806
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic significance of left ventricular systolic dyssynchrony in patients with nonischemic dilated cardiomyopathy.
    Karaahmet T; Tigen K; Mutlu B; Gürel E; Cevik C; Kahveci G; Tanalp AC; Başaran Y
    Turk Kardiyol Dern Ars; 2009 Jul; 37(5):301-6. PubMed ID: 19875901
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Impact of Infarct Location and Extent on LV Motion Patterns: Implications for Dyssynchrony Assessment.
    Steelant B; Stankovic I; Roijakkers I; Aarones M; Bogaert J; Desmet W; Aakhus S; Voigt JU
    JACC Cardiovasc Imaging; 2016 Jun; 9(6):655-64. PubMed ID: 27085438
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Adverse response to cardiac resynchronisation therapy in patients with septal scar on cardiac MRI preventing a septal right ventricular lead position.
    Duckett SG; Ginks M; Shetty A; Kirubakaran S; Bostock J; Kapetanakis S; Gill J; Carr-White G; Razavi R; Rinaldi CA
    J Interv Card Electrophysiol; 2012 Mar; 33(2):151-60. PubMed ID: 22127378
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Usefulness and limitation of dobutamine stress echocardiography to predict acute response to cardiac resynchronization therapy.
    Sénéchal M; Lancellotti P; Garceau P; Champagne J; Dubois M; Magne J; Blier L; Molin F; Philippon F; Dumesnil JG; Pierard L; O'Hara G
    Echocardiography; 2010 Jan; 27(1):50-7. PubMed ID: 19725852
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Worsening of left ventricular end-systolic volume and mitral regurgitation without increase in left ventricular dyssynchrony on acute interruption of cardiac resynchronization therapy.
    Kuppahally SS; Fowler MB; Vagelos R; Wang P; Al-Ahmad A; Paloma A; Liang D
    Echocardiography; 2009 Aug; 26(7):759-65. PubMed ID: 19558521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.